NCT05270616 Robotic Versus Video-assisted Lobectomy/Segmentectomy for Lung Surgery
| NCT ID | NCT05270616 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Second Hospital of Shandong University |
| Condition | Lung Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 800 participants |
| Start Date | 2020-06-01 |
| Primary Completion | 2023-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 800 participants in total. It began in 2020-06-01 with a primary completion date of 2023-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To compare the safety/efficacy of the robotic-assisted lobectomy/segmentectomy (RAL/S) with the video-assisted lobectomy/segmentectomy (VAL/S) for lung resection. Video-assisted lobectomy/segmentectomy (VAL/S) for lung resection is divided into uniport group and multiple- port group.
Eligibility Criteria
Inclusion Criteria: 1. good cardio- pulmonary function to tolerate surgery; 2. minimaly invasive surgery for lobectomy or segmentectomy or sleeve lobectomy; Exclusion Criteria: 1. cardio- pulmonary function is not good enough to tolerate surgery; 2. huge tumor or extensive adhesion in thoracic cavity.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05270616 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Lung Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05270616 currently recruiting?
Yes, NCT05270616 is actively recruiting participants. Contact the research team at zhaoxiaogang@sdu.edu.cn for enrollment information.
Where is the NCT05270616 trial being conducted?
This trial is being conducted at Jinan, China.
Who is sponsoring the NCT05270616 clinical trial?
NCT05270616 is sponsored by The Second Hospital of Shandong University. The trial plans to enroll 800 participants.